OPERA – 5 years results
12 May 2026
The OPERA trial has shown that a contact X-ray brachytherapy 50 kV (CXB) boost with neoadjuvant
chemoradiotherapy (NCRT) can increase organ preservation (OP) rate for early rectal adenocarcinoma (ADK) of lowmid rectum.
chemoradiotherapy (NCRT) can increase organ preservation (OP) rate for early rectal adenocarcinoma (ADK) of lowmid rectum.